Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-Epigenetics-Bromodomain-Trotabresib
Trotabresib

Chemical Structure : Trotabresib

CAS No.: 1706738-98-8

Trotabresib (CC-90010, CC90010, QC5487)

Catalog No.: PC-38040Not For Human Use, Lab Use Only.

Trotabresib (CC90010) is a reversible and orally active BET bromodomain inhibitor, shows significant antiproliferative activity in glioblastoma cells and patient-derived xenograft models as monotherapy and in combination with temozolomide (TMZ).

Packing Price Stock Quantity
5 mg $128 In stock
10 mg $198 In stock
25 mg $328 In stock
50 mg $528 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Trotabresib (CC90010) is a reversible and orally active BET bromodomain inhibitor, shows significant antiproliferative activity in glioblastoma cells and patient-derived xenograft models as monotherapy and in combination with temozolomide (TMZ).

Physicochemical Properties

M.Wt 383.462
Formula C21H21NO4S
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

1(2H)-Isoquinolinone, 4-(2-(cyclopropylmethoxy)-5-(methylsulfonyl)phenyl)-2-methyl-

References

1. Moreno V, et al. Ann Oncol. 2020 Jun;31(6):780-788.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: